Ligand Structure Research Articles

Synthesis of Quinoline-based New Organic Chemosensors and its Application in Fluorophoric Detection of Metal-ions in Environmental Samples and Confirmation of Results using Molecular Modelling: A Complete Study

Quinoline-based two new ligands have been synthesized (QL1 and QL2) by reacting 8-quinoline carboxylic acid with derivatives of L-valine under a condensation reaction. The synthesized ligands were characterized by spectroscopic techniques such as 1H NMR, UV, IR, HRMS and CHNS. The 3D structures of both ligands were optimized for the lowest energy and the HOMO-LUMO orbitals were developed. The photoluminescence analysis of both ligands showed the fluorescence emission wavelengths on 492 and 508 nm, respectively for QL1 and QL2. The substituents on the quinoline ring influence the change in fluorescence emission wavelengths. Synthesized ligands acted as selective fluorescence turn-off chemosensors for Cu2+ ions and demonstrated the sensitive detection of Cu2+ ions in different water samples at the nanomolar scale. The interaction between metal ion and ligands were also studied by developing DFT structures.

Organosilicon-Based Ligand Design for High-Performance Perovskite Nanocrystal Films for Color Conversion and X-ray Imaging.

Perovskite nanocrystals (PNCs) bear a huge potential for widespread applications, such as color conversion, X-ray scintillators, and active laser media. However, the poor intrinsic stability and high susceptibility to environmental stimuli including moisture and oxygen have become bottlenecks of PNC materials for commercialization. Appropriate barrier material design can efficiently improve the stability of the PNCs. Particularly, the strategy for packaging PNCs in organosilicon matrixes can integrate the advantages of inorganic-oxide-based and polymer-based encapsulation routes. However, the inert long-carbon-chain ligands (e.g., oleic acid, oleylamine) used in the current ligand systems for silicon-based encapsulation are detrimental to the cross-linking of the organosilicon matrix, resulting in performance deficiencies in the nanocrystal films, such as low transparency and large surface roughness. Herein, we propose a dual-organosilicon ligand system consisting of (3-aminopropyl)triethoxysilane (APTES) and (3-aminopropyl)triethoxysilane with pentanedioic anhydride (APTES-PA), to replace the inert long-carbon-chain ligands for improving the performance of organosilicon-coated PNC films. As a result, strongly fluorescent PNC films prepared by a facile solution-casting method demonstrate high transparency and reduced surface roughness while maintaining high stability in various harsh environments. The optimized PNC films were eventually applied in an X-ray imaging system as scintillators, showing a high spatial resolution above 20 lp/mm. By designing this promising dual organosilicon ligand system for PNC films, our work highlights the crucial influence of the molecular structure of the capping ligands on the optical performance of the PNC film.

Prediction of viral protease inhibitors using proteochemometrics approach

Being widely accepted tools in computational drug search, the (Q)SAR methods have limitations related to data incompleteness. The proteochemometrics (PCM) approach expands the applicability area by using description for both protein and ligand structures. The PCM algorithms are urgently required for the development of new antiviral agents. We suggest the PCM method using the TLMNA descriptors, combining the MNA descriptors of ligands and protein sequence N-grams. Our method was validated on the viral chymotrypsin-like proteases and their ligands. We have developed an original protocol allowing us to collect a comprehensive set of 15 protein sequences and more than 9000 ligands from the ChEMBL database. The N-grams were derived from the 3D-based alignment, accurately superposing ligand-binding regions. In testing the ligand set in SAR mode with MNA descriptors, an accuracy above 0.95 was determined that shows the perspective of the antiviral drug search in virtual chemical libraries. The effective PCM models were built with the TLMNA descriptor. The strong validation procedure with pair exclusion simulated the prediction of interactions between the new ligands and new targets, resulting in accuracy estimation up to 0.89. The PCM approach shows slightly lower accuracy caused by more uncertainty compared with SAR, but it overcomes the problem of data incompleteness.

Palladium(II) NCS‐Pincer Complexes Mediated Regioselective Cross Dehydrogenative Alkenation of 2‐Arylthiophenes

In this report, we have synthesized two NCS pincer ligands by the Schiff base reaction of 3‐((phenylthio)methoxy)benzaldehyde (P) with alkyl amines (tbutylamine (L1) and 1‐adamantylamine (L2)). The palladium pincer complexes (tbutylamine = C1 and 1‐adamantylamine = C2) of these ligands were synthesized by their reaction with PdCl2(CH3CN)2. The newly synthesized ligands and complexes were characterized using various techniques such as 1H, 13C{1H} Nuclear Magnetic Resonance (NMR), Ultraviolet–visible (UV‐Visible), Fourier Transform Infrared (FTIR) Spectroscopy, and High‐Resolution Mass Spectrometry (HRMS). The structure of ligand and its coordination mode with palladium precursor were studied with the help of single‐crystal X‐ray diffraction. The complexes showed distorted square planar geometry around the palladium center. The palladium pincer complexes were used as catalysts for the regioselective cross‐dehydrogenative alkenation of 2‐arylthiophene derivatives. The complex C2, where sterically bulky adamantyl ligand is part of the side arm showed a higher yield of alkenation reaction. Only 2.5 mol% catalyst loading was sufficient to achieve 74‐95% yields of desired products with excellent functional group tolerance under mild reaction conditions. The poisoning experiments (PPh3 and Hg) showed the homogeneous nature of the catalytic process. The plausible mechanism of the reaction was proposed based on the control experiments and time‐dependent HRMS studies.

Covalent and Visible‐Light Photoswitchable Derivatives of the Potent Synthetic Opioid Isotonitazene and Other Nitazenes

Isotonitazene belongs to a potent class of m‐opioid receptor (µOR) ligands, known as nitazenes. The lack of knowledge surrounding this agonist and others in its class has sparked thorough re‐investigations. To aid in these investigations, the purportedly covalent yet underexplored nitazene BIT was biochemically re‐evaluated in this work, along with a newly synthesized analogue, Iso‐BIT. Moreover, in the pursuit of understanding the mechanism, function, and interactions of µOR, this study involved developing photoswitchable derivatives of nitazene as potential probe molecules. Converting known ligands into azo‐containing photoswitchable derivatives offers the opportunity to modulate ligand structure with light, allowing for photocontrol of compound activity. While photocontrol of µOR activity could not be entirely achieved, photophysical evaluation of these arylazobenzimidazole derivatives revealed a novel photoswitch scaffold that responds to visible light. Furthermore, azo‐containing 2e and 3e emerged as promising nitazene derivatives that were able to form an exceptionally high fraction of covalent‐ligand receptor complexes with wild‐type µOR at physiological pH.

Ab initio modeling of human IRS1 protein to find novel target to dock with drug MH to mitigateT2DM diabetes by insulin signaling.

IRS1 is a cytoplasmic adaptor protein that helps incellulargrowth, glucose metabolism, proliferation, anddifferentiation. Highly disordered (insulin receptor substrate 1) IRS1 protein sequence (mol.wt- 131,590.97da) has been used to develop model using ab initio modeling technique by I-Tassar tool and Discovery Studio/ DogSite Server to decipher a novel active site. The constructed protein model has been submitted with PMDB Id- PM0082210. GRAVY index of IRS1 model ( - 0.675) indicated surface protein-water interaction. Protparam tool instability index (75.22) demonstrated disorderedness combined with loops owing to prolines/glycines. After refinement,the Ramachandran plot showed that 88 percent of AAs were presentin the allowed region and only 0.5% in the disallowed region.Novel IRS1 model proteinhas 10 α-helices, 22 β-sheets, 20 β-hairpins, 5 β-bulges, 47 strands, 105 β-turns, and 8 γ-turns. Docking of IRS1 with drug MH demonstrated interaction of Ser-70, Thr-18, and Pro-69 with C-H bonds; Gln-71, and Glu-113 with hydrogen bonds; while both Glu-114 and Glu-113 with salt-bridge connection. Permissible 1.0-1.5Å range of RMSD fluctuation between 20 and 45ns was obtained in simulation of IRS1 and IRS1-met complex confirmed that both complexes were stable during whole simulation process. RMSF result showed that except positions 57AA and 114AA, the binding of drug had no severe effects on the flexibility of the IRS1 and IRS1-met complex. The RoG value of compactness and rigidity showed little change in IRS1 protein. SASA value of IRS1 indicated non-significant fluctuation between IRS1 and drug MH means ligand (drug) and IRS1 receptor form stable structure. Hydrogen bond strength of IRS1 and IRS1-met was 81.2 and 76.4, respectively, which suggested stable interaction.

Boron Complexes of Tridentate Acyl Pyridylhydrazones

AbstractSince the development of the chemistry and applications of boron dipyrromethene dyes (BODIPYs), numerous other platforms based on boron complexes of N‐donor ligands have emerged as molecular optoelectronic materials. By tailoring the structure of the ligand bound to boron, the optical and electronic properties of a compound can be precisely tuned for unique properties, such as aggregation‐induced emission (AIE) in the case of boron difluoride hydrazones (BODIHYs). We examine the impact of modifying the typical bidentate hydrazone ligand structure used to prepare BODIHYs to enable a tridentate coordination mode to produce boron complexes of tridentate acyl pyridylhydrazones. This change allows for the use of arylboronic acids as sources of boron and facilitates the inclusion of complex organic components at the boron centre, including the formation of dye‐dye conjugates. The synthesized compounds exhibit distinct optical and electronic properties when compared to BODIHYs, such as reversible electrochemical reduction and up to a >300 nm pseudo‐Stokes shift in the solid state, all of which were supported by density functional theory calculations.

Mono- and bi-nuclear phosphine-phenolate neutral nickel catalysts via simple Schiff-Base condensation for ethylene polymerization

In catalytic olefin polymerization, a significant amount of effort has been invested to modify either phosphine substituent or ligand backbone in recently advanced phosphine-phenolate [P,O] neutral nickel catalysts. Unlike other commonly used ligands like phenoxy-imines [N,O] and α-diimines [N,N], [P,O] ligands often require a laborious synthesis technique, which has hindered the rational design of ligand structures and the development of new catalysts. Here we present a novel and effective strategy for creating catalysts using [N,O,P] hybrid ligands. The substituent adjacent to the phenoxy group can be efficiently modified through straightforward Schiff-base condensation reactions with various amines that have established synthetic routes and diverse structures. This process results in the preparation of a series of highly active [P,O] nickel catalysts (up to 1.7 × 107 g mol-1h−1) that are capable of producing ultrahigh molecular weight polyethylene (UHMWPE) (Mw = 243.7 × 104 g/mol) in ethylene polymerization. The additional binding site greatly facilitates modulation of catalytic properties by additives, and parameters such as catalytic activity, polymer molecular weight, and polymer branching can be tuned in this way. Furthermore, binuclear [P,O] neutral nickel catalysts for olefin polymerization are synthesized for the first time using a sequence of diamines. The strategy presented in this work greatly improves the efficiency for the design and synthesis of [P,O] nickel and related catalysts. These findings will be advantageous for future catalyst design and screening.

Effect of ligand structure and metal center on ethylene oligomerization with N, N′ Schiff base late transition complexes: experiments and calculations

A series of N, N’ bis(pyridine-imine) Schiff base late transition metal (Fe, Co, and Ni) complexes with different ligand structures and catalytic active sites were synthesized. Ethylene oligomerization results showed that bis(pyridine-imine) iron complex had the highest catalytic activity (10.8 × 105 g/mol Fe h), and the catalytic activity of cobalt complex was the lowest (2.5 × 105 g/mol Co h); nickel complex had the highest selectivity toward high carbon olefins (28.6%), while the iron complex had the lowest (0.2%). The structure-activity relationship between the catalyst structure and catalytic properties for ethylene oligomerization was further studied by density functional theory (DFT) calculations. The bis(pyridine-imine) iron complex had the highest energy gap value and the most stable catalyst structure, which was more conducive to oligomerization; and the N–M–N bond of the nickel complex had the smallest bond angle, which was beneficial for chain growth. Based on the Cossee mechanism, a mechanism for ethylene oligomerization catalyzed by bis(pyridine-imine) metal complexes was proposed. To further study the micro reaction process of ethylene oligomerization, a molecular model of pyridine imine nickel complex and its catalytic ethylene oligomerization reaction path were proposed. The structure and energy of the reaction intermediate and transition state were calculated using DFT. The molecular model of the nickel complex had a lower ethylene insertion barrier and β-H elimination of energy barriers, indicating that the molecular model of the pyridine imine nickel complex had ethylene oligomerization active centers.

Zirconium-containing nanoscale coordination polymers for positron emission tomography and fluorescence-guided cargo delivery to triple-negative breast tumors

Nanoscale coordination polymer (NCP) is a class of hybrid materials formed by self-assembly of metal ions and organic ligands through coordination. The applications of NCP in biomedicine are quite extensive due to the diversity choice of metal ions and organic ligands. Here we designed Zr-P1 NCP based on Zr4+ selected as metal ion nodes and tetrakis(4-carboxyphenyl) ethylene as bridging ligands. Zr-P1 NCP was modified with functionalized pyrene derived polyethylene glycol (Py-PAA-PEG-Mal) on the surface and further conjugated with cRGD for active targeting of integrin αvβ3 overexpressed in triple-negative breast cancer. Doxorubicin was loaded on Zr-P1 NCP with encapsulation efficiency up to 22 % for the treatment of triple negative breast cancer. 89Zr-P1 NCP can be used for in vivo tumor imaging due to the fluorescence properties resulting from the enhanced aggregation-induced Emission (AIE) behavior of P1 ligands and its positron emission tomography (PET) capability. Cellular evaluation indicated that the functionalized Zr-P1@PEG-RGD presented a good function for tumor cell targeting imaging and doxorubicin could be targeted to triple negative breast cancer when it was loaded onto Zr-P1@PEG-RGD, which corroborated with the in vivo results. In summary, 89Zr-P1@PEG-RGD can serve as a biocompatible nanoplatform for fluorescence and PET image-guided cargo delivery. Statement of SignificanceNanoscale coordination polymer (NCP) is a class of hybrid materials formed by self-assembly of metal ions and organic ligands through coordination. The diversity of available metals and ligand structures upon NCP synthesis plays an advantage in establishing multimodal imaging platforms. Here we designed 89Zr-P1@PEG-RGD NCP based on Zr4+ selected as metal ion nodes and tetrakis(4-carboxyphenyl) ethylene as bridging ligands. 89Zr-P1@PEG-RGD nanomaterials have positron emission tomography (PET) capability due to the incorporation of zirconium-89, which can be used for in vivo tumor imaging with high sensitivity. The chemotherapeutic drug DOX was loaded on Zr-P1 NCP for the treatment of triple-negative breast cancer, and dual modality imaging can provide visual guidance for drug delivery.

A strategy to enhance the water solubility of luminescent β-diketonate-Europium(III) complexes for time-gated luminescence bioassays

Luminescent β-diketonate-europium(III) complexes have been found a wide range of applications in time-gated luminescence (TGL) bioassays, but their poor water solubility is a main problem that limits their effective uses. In this work we propose a simple and general strategy to enhance the water solubility of luminescent β-diketonate-europium(III) complexes that permits facile synthesis and purification. By introducing the fluorinated carboxylic acid group into the structures of β-diketone ligands, two highly water-soluble and luminescent Eu3+ complexes, PBBHD-Eu3+ and CPBBHD-Eu3+, were designed and synthesized. An excellent solubility exceeding 20 mg/mL for PBBHD-Eu3+ was found in a pure aqueous buffer, while it also displayed strong and long-lived luminescence (quantum yield ϕ = 26%, lifetime τ = 0.49 ms). After the carboxyl groups of PBBHD-Eu3+ were activated, the PBBHD-Eu3+-labeled streptavidin-bovine serum albumin (SA-BSA) conjugate was prepared, and successfully used for the immunoassay of human α-fetoprotein (AFP) and the imaging of an environmental pathogen Giardia lamblia under TGL mode, which demonstrated the practicability of PBBHD-Eu3+ for highly sensitive TGL bioassays. The carboxyl groups of PBBHD can also be easily derivatized with other reactive chemical groups, which enables PBBHD-Eu3+ to meet diverse requirements of biolabeling technique, to provide new opportunities for developing functional europium(III) complex biolabels serving for TGL bioassays.

Novel half-sandwich ruthenium(II) nicotinic hydrazone complexes: An efficient class of catalyst for the N-alkylation of amines with benzyl alcohol via transfer hydrogen mechanism and effective antibacterial agents

A new series of half sandwich ruthenium(II) complexes supported by nicotinic acid hydrazone derivatives of general formula [Ru(ɳ6-p-cymene)(Cl)(L)], where L represents N’-benzylidenenicotinohydrazide (HL1), N’-(naphthalen-1-ylmethylene)nicotinohydrazide (HL2) or N’-(pyren-1-ylmethylene)nicotinohydrazide (HL3) were synthesized and fully characterized. The solid-state molecular structures of ligands and complexes were elucidated with single-crystal X-ray diffraction. The ligands HL1 and HL2 possess monoclinic crystal system with P21/c and C2/c space groups respectively, whereas all the three Ru(II) complexes C1–3 are typical three-legged piano-stool geometries with orthorhombic(Aba2) (C1) and triclinic(P-1) (C2–3) systems respectively. The catalytic activities of these ruthenium complexes in the synthesis of N-alkylated amines were explored. Under optimal reaction condition, the complex C3 was found to be the most efficient catalyst for the N-alkylation of primary to secondary amines using benzyl alcohol. A wide range of substrates have been studied that includes anilines bearing electron withdrawing/electron donating group, fused aromatic, heteroaromatic, alicyclic and aliphatic amines with good to excellent yield. In addition, the antibacterial activity of the complexes were tested against different human pathogenic bacteria, among them C2 complex with naphthyl moiety was found to be the most active one against both Gram-positive (S. aureus and E. faecalis) and Gram-negative (E. coli and K. pneumoniae) bacteria. These two different studies demonstrate the catalytic and biological importance of our newly prepared Ruthenium complex.

Computationally Guided Ligand Discovery from Compound Libraries and Discovery of a New Class of Ligands for Ni-Catalyzed Cross-Electrophile Coupling of Challenging Quinoline Halides.

Although screening technology has heavily impacted the fields of metal catalysis and drug discovery, its application to the discovery of new catalyst classes has been limited. The diversity of on- and off-cycle pathways, combined with incomplete mechanistic understanding, means that screens of potential new ligands have thus far been guided by intuitive analysis of the metal binding potential. This has resulted in the discovery of new classes of ligands, but the low hit rates have limited the use of this strategy because large screens require considerable cost and effort. Here, we demonstrate a method to identify promising screening directions via simple and scalable computational and linear regression tools that leads to a substantial improvement in hit rate, enabling the use of smaller screens to find new ligands. The application of this approach to a particular example of Ni-catalyzed cross-electrophile coupling of aryl halides with alkyl halides revealed a previously overlooked trend: reactions with more electron-poor amidine ligands result in a higher yield. Focused screens utilizing this trend were more successful than serendipity-based screening and led to the discovery of two new types of ligands, pyridyl oxadiazoles and pyridyl oximes. These ligands are especially effective for couplings of bromo- and chloroquinolines and isoquinolines, where they are now the state of the art. The simplicity of these models with parameters derived from metal-free ligand structures should make this approach scalable and widely accessible.

Tuning the luminescence color of Eu3+- and alkali-ion-codoped Sr2CaWO6 orange-red phosphors: Eu3+ site distribution and site-selective photoluminescence studies

In this study, Eu3+- and alkali-ion (M+)-codoped Sr2CaWO6:x (Eu3+, M+) (x = 0.01–0.10) were synthesized via a solid-state reaction. The effects of different Sr/Ca ratios, types of monovalent metal ions (M+ = Na+, K+, and Li+), and doping concentrations were systematically investigated. The crystalline phase, photoluminescence (PL) properties, lattice site occupied by the Eu3+ ion, Eu3+ site distribution, and site-selective PL properties were evaluated by x-ray diffraction, PL/photoluminescence excitation (PLE) spectroscopy with a monochromatic light source, PL quantum efficiency (QE) measurements, and high-resolution PL/PLE spectroscopy with a wavelength-tunable laser. A dependence of the PL asymmetry ratio for the 5D0–7F1,2 transitions on the Sr/Ca ratio was identified and quantified for the first time. Based on the site-selective PL measurements, this behavior was ascribed to the enhancement of Eu3+ local distortion by Sr2+ substitution at the A site at lower Sr/Ca ratios (<2) and to the high symmetry of the ligand structure of EuO6 octahedra owing to Ca2+ substitution at the B site at higher Sr/Ca ratios (>2). The PLE results provided insight into the Eu3+ site distribution, which explained the orange-red PL and PL QEs of the synthesized phosphors.

Ir Single Atoms Boost Metal-Oxygen Covalency on Selenide-Derived NiOOH for Direct Intramolecular Oxygen Coupling.

This investigation probes the intricate interplay of catalyst dynamics and reaction pathways during the oxygen evolution reaction (OER), highlighting the significance of atomic-level and local ligand structure insights in crafting highly active electrocatalysts. Leveraging a tailored ion exchange reaction followed by electrochemical dynamic reconstruction, we engineered a novel catalytic structure featuring single Ir atoms anchored to NiOOH (Ir1@NiOOH). This novel approach involved the strategic replacement of Fe with Ir, facilitating the transition of selenide precatalysts into active (oxy)hydroxides. This elemental substitution promoted an upward shift in the O 2p band and intensified the metal-oxygen covalency, thereby altering the OER mechanism toward enhanced activity. The shift from a single-metal site mechanism (SMSM) in NiOOH to a dual-metal-site mechanism (DMSM) in Ir1@NiOOH was substantiated by in situ differential electrochemical mass spectrometry (DEMS) and supported by theoretical insights. Remarkably, the Ir1@NiOOH electrode exhibited exceptional electrocatalytic performance, achieving overpotentials as low as 142 and 308 mV at current densities of 10 and 1000 mA cm-2, respectively, setting a new benchmark for the electrocatalysis of OER.

The Copper Reduction Potential Determines the Reductive Cytotoxicity: Relevance to the Design of Metal-Organic Antitumor Drugs.

Copper-organic compounds have gained momentum as potent antitumor drug candidates largely due to their ability to generate an oxidative burst upon the transition of Cu2+ to Cu1+ triggered by the exogenous-reducing agents. We have reported the differential potencies of a series of Cu(II)-organic complexes that produce reactive oxygen species (ROS) and cell death after incubation with N-acetylcysteine (NAC). To get insight into the structural prerequisites for optimization of the organic ligands, we herein investigated the electrochemical properties and the cytotoxicity of Cu(II) complexes with pyridylmethylenethiohydantoins, pyridylbenzothiazole, pyridylbenzimidazole, thiosemicarbazones and porphyrins. We demonstrate that the ability of the complexes to kill cells in combination with NAC is determined by the potential of the Cu+2 → Cu+1 redox transition rather than by the spatial structure of the organic ligand. For cell sensitization to the copper-organic complex, the electrochemical potential of the metal reduction should be lower than the oxidation potential of the reducing agent. Generally, the structural optimization of copper-organic complexes for combinations with the reducing agents should include uncharged organic ligands that carry hard electronegative inorganic moieties.

Construction of Smart DNA-Based Drug Delivery Systems for Cancer Therapy.

Due to the disadvantages of poor targeting, slow action, and low effectiveness of current commonly used cancer treatments, including surgery, chemotherapy, and radiotherapy, researchers have turned to DNA as a biomaterial for constructing drug delivery nanocarriers. DNA is favored for its biocompatibility and programmability. In order to overcome the limitations associated with traditional drug delivery systems (DDSs), researchers have developed smart-responsive DNA DDSs that can control drug release in response to specific physical or chemical stimuli at targeted sites. In this review, a summary of multiple targeted ligand structures is provided, various shapes of stable DNA nanomaterials, and different stimuli-responsive drug release strategies in DNA DDSs. Specifically, targeted cell recognition, in vivo stable transport, and controlled drug release of smart DDSs are focused. Finally, the further development prospects and challenges of clinical application of DNA nanomaterials in the field of smart drug delivery are discussed. The objective of this review is to enhance researchers' comprehension regarding the potential application of DNA nanomaterials in precision drug delivery, with the aim of expediting the clinical implementation of intelligent DDSs.

A perspective into ring-opening polymerization of ε-caprolactone and lactides: effect of, ligand, catalyst structure and system dynamics, on catalytic activity and polymer properties

AbstractPolylactic acid (PLAs) and polycaprolactones (PCLs) are emerging to be polyesters of choice because they are biodegradable and biocompatible. The industrial viable method currently used for their production is catalytic ring-opening polymerization (ROP) of their respective cyclic ester monomers. The catalyst is at the core of ROP chemical transformation and as such research is dedicated towards the innovation of more efficient and selective catalysts. Catalyst structural features greatly influence catalyst performance in ROP, and this review discusses the effects of ligand and catalyst structure and system dynamics, on catalytic activity and polymer properties. The effects of associated catalyst components such as initiating groups, ligand chirality, and stereochemical in relation to catalyst activity and polymer properties were also reviewed. The effects of metal nuclearity and catalyst flexibility on catalytic activity were also reviewed. The effect of solvent and temperature was briefly considered. Graphical abstract

Experimental and theoretical studies of methyl 1-(2-chloroacetyl)-4-hydroxy-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3-carboxylate: Insights from synthesis, spectroscopic, crystal structure, Hirshfeld surface, DFT, ELF, RDG, IRI, ADMET and docking studies

Methyl 1-(2-chloroacetyl)-4‑hydroxy-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3-carboxylate (compound 2) was synthesized by the condensation of 3-carboxymethyl-2,6-diphenylpiperidine-4-one with chloroacetylchloride, and characterized by FT-IR spectroscopy. Further confirmation of the molecular structure was obtained by the single crystal X-ray diffraction (SC-XRD) technique. The study revealed that the piperidine ring adopts boat conformation with equatorial orientation of two phenyl rings at C-2 and C-6. Intermolecular contacts and hydrogen bonding interactions were explored by Hirshfeld surface and 2D fingerprint analyses, showing that the major contact were H∙∙∙H (57.7 %), C∙∙∙H/H∙∙∙C (14.2 %), O∙∙∙H/H∙∙∙O (15.3), Cl∙∙∙H/H∙∙∙Cl (7.1 %) and C∙∙∙Cl/Cl∙∙∙C (12.7 %). Intramolecular interaction was examined through the Radiant density gradient (RDG), Interaction region indicator (IRI), Electron localization function (ELF), and localized orbital locator (LOL) to understand hyperconjugration and π-electrons delocalization in the molecule. DFT studies such as structure optimization, HOMO-LUMO orbital analysis and molecular electrostatic potential were conducted for the title compound. The topology of the molecular arrangement and intermolecular interaction energies were determined through 3D energy framework analysis. Subsequently, the compound 2 was subjected to ADMET analysis to extend its scope of bioavailability. Molecular docking studies were then employed using the tyrosine kinase inhibitor, epidermal growth factor receptor (EGFR) enzymes (PDB ID: 4WKQ and 6JOL). The study revealed significant interactions between the title ligand structure and active sites of selected proteins complex.

Ligand structure optimization leads to efficient acid-resist Am(III)/Eu(III) separation in n-octanol

Liquid-liquid extraction is the most wildly adopted industrial Lns/Ans separation approach which takes advantages of the subtle atomic size differences for Lns and Ans. Preorganized ligand architecture with coordination configuration locking strategy has been proven to be very efficient to enhance the separation factors by size exclusive effect from the preset ligand cavity while drawbacks such as sophisticated ligand synthesis, unbalanced extraction/stripping performances and limited solubility in environmental benign solvents prevent the economic practicability. In the current contribution, calculation-guided ligand structure optimization was utilized to optimize the hard/soft tetradentate phenanthroline diamide ligands. Reducing the number of alkyl chains around the binding sites from amide to imide led to less rotation energy barriers, eventually boosted both metal distributions and separation factors. Additionally, the formation of hydrogen bonds in the imine ligands enhanced their solubility in industrial-friendly solvent, such as n-octanol, leading to superior extraction performances. Finally, balanced extraction, stripping and recycling of the reported ligands were demonstrated to unravel the potential to be integrated into current industrial plants. The ligand design philosophy as discussed in this work could inspire the searching for new environment-friendly high-performance lipophilic ligand to close the current nuclear fuel cycle.